Veery Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-427
Closed -$202K 102
2026
Q1
$202K Buy
+427
New +$215K 0.06% 96
2024
Q4
Sell
-654
Closed -$266K 94
2024
Q3
$266K Sell
654
-58
-8% -$21.2K 0.1% 73
2024
Q2
$229K Buy
712
+2
+0.3% +$650 0.09% 86
2024
Q1
$237K Buy
+710
New +$217K 0.1% 82
2023
Q3
Sell
-739
Closed -$224K 86
2023
Q2
$224K Sell
739
-43
-5% -$12K 0.11% 74
2023
Q1
$206K Buy
+782
New +$199K 0.11% 76
2022
Q2
Sell
-901
Closed -$226K 79
2022
Q1
$226K Buy
901
+12
+1% +$3.01K 0.13% 73
2021
Q4
$228K Sell
889
-7
-0.8% -$1.71K 0.12% 72
2021
Q3
$217K Buy
+896
New +$219K 0.12% 71

Other funds holding HCA

Veery Capital's HCA Position: Q2 2026 in Review

Veery Capital sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 427 shares — an estimated $202K sold.

Veery Capital first reported a position in HCA in Q3 2021 and held it in 9 quarters. The position peaked at $266K in Q3 2024. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Veery Capital reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Veery Capital sold 427 HCA Healthcare shares in Q2 2026, an estimated $202K.
  • Veery Capital first reported a position in HCA Healthcare in Q3 2021 and held it in 9 quarters.
  • Veery Capital's HCA Healthcare position peaked at $266K in Q3 2024.
  • 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.